SRS versus WBRT for resected brain metastases Reply

被引：0
|
作者：
Roberge, David [1 ]
Brown, Paul [2 ]
机构：
[1] Ctr Hosp Univ Montreal, Dept Radiat Oncol, Montreal, PQ, Canada
[2] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 10期
关键词：
POSTOPERATIVE STEREOTACTIC RADIOSURGERY; PHASE-3; TRIAL; RADIOTHERAPY;
D O I：
10.1016/S1470-2045(17)30703-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E560 / E560
页数：1
相关论文
共 50 条
  • [21] Comparative Effectiveness of Stereotactic Radiosurgery (SRS) Versus Whole Brain Radiation Therapy (WBRT) for Patients With Brain Metastases From Non-Small Cell Lung Cancer (NSCLC)
    Halasz, L. M.
    Uno, H.
    Zornosa, C.
    D'Amico, T. A.
    Dexter, E. U.
    Hayman, J. A.
    Otterson, G. A.
    Pisters, K. M.
    Weeks, J. C.
    Punglia, R. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S41 - S41
  • [22] Stereotactic radiosurgery with or without WBRT for brain metastases
    Fogarty, Gerald B.
    Hong, Angela
    Paton, Elizabeth
    Li, Patricia
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (01): : 219 - 220
  • [23] Postoperative Stereotactic Radiosurgery (SRS) without Whole-brain Radiation Therapy (WBRT) for Brain Metastases: Potential Role of Tumor Size
    Hartford, A. C.
    Paravati, A.
    Spire, W.
    Jarvis, L.
    Erkmen, K.
    Friedman, J.
    Li, Z.
    Hug, E.
    Roberts, D.
    Simmons, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S273 - S273
  • [24] Cost-effectiveness analysis based on neurocognitive function of a randomized study with stereotactic radiosurgery (SRS) alone versus SRS plus whole-brain radiation therapy (WBRT) for patients with one to three brain metastases.
    Lal, L.
    Wefel, J. S.
    Meyers, C. A.
    Chang, E. L.
    Franxini, L.
    Reasonda, L. G.
    Feng, C.
    Swint, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis
    Khan, Muhammad
    Lin, Jie
    Liao, Guixiang
    Li, Rong
    Wang, Baiyao
    Xie, Guozhu
    Zheng, Jieling
    Yuan, Yawei
    TUMOR BIOLOGY, 2017, 39 (07) : 1 - 14
  • [26] Secondary Analysis of RTOG 9508, a Phase 3 Randomized Trial of Whole Brain Radiation Therapy (WBRT) Versus WBRT Plus Stereotactic Radiosurgery (SRS) in Patients With 1-3 Brain Metastases; Poststratified by the Graded Prognostic Assessment (GPA)
    Sperduto, P. W.
    Shanley, R.
    Luo, X.
    Andrews, D.
    Werner-Wasik, M.
    Valicenti, R.
    Bahary, J.
    Souhami, L.
    Won, M.
    Mehta, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S51 - S52
  • [27] Cost-effectiveness analysis of a randomized study with stereotactic radiosurgery (SRS) alone versus SRS plus whole brain radiation therapy (WBRT) for patients with brain metastasis
    Lal, L. S.
    Chang, E. L.
    Franzini, L.
    Arbuckle, R. B.
    Miller, L.
    Reasonda, L. G.
    Feng, C.
    Swint, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] RETROSPECTIVE ANALYSIS TO DETERMINE THE FREQUENCY OF SYMPTOMATIC NEW BRAIN METASTASES DURING ROUTINE MRI SURVEILLANCE POST-SRS OR -WBRT
    Eichorn, Daniel
    Ali, Usman
    Lesenskyj, Alexa
    Potts, Alexa
    Trivedi, Varahi
    Patchell, Roy
    Chen, Timothy
    Williamson, Shirnett
    Maxwell, Christina
    Mintz, Arlan
    NEURO-ONCOLOGY, 2016, 18 : 29 - 29
  • [29] adjuvant radiosurgery versus conformal radiation therapy for resected brain metastases
    Shah, S.
    Rastogi, S.
    Hanlon, A.
    Shukla, G.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S913 - S914
  • [30] A radiomics-based model for predicting local control of resected brain metastases receiving adjuvant SRS
    Mulford, Kellen
    Chen, Chuyu
    Dusenbery, Kathryn
    Yuan, Jianling
    Hunt, Matthew A.
    Chen, Clark C.
    Sperduto, Paul
    Watanabe, Yoichi
    Wilke, Christopher
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 29 : 27 - 32
12345